Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2010
12/01/2010CN101897685A Composition containing sibutramine and fibrate lipid-lowering drugs
12/01/2010CN101897673A Method for preparing vitamin C tablet
12/01/2010CN101897671A Xylitol micro pill preparations and preparation method thereof
12/01/2010CN101897662A Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
12/01/2010CN101897529A Medicament health-care pillow
12/01/2010CN101897432A Health-care product having function of blood sugar reduction
12/01/2010CN101606939B Fat-soluble vitamin freeze-dried powder needle and preparation method thereof
12/01/2010CN101428132B Chinese medicinal composition for treating hyperlipemia and preparation thereof
12/01/2010CN101391071B Traditional Chinese medicine for treating diabetic ocular fundus diseases
12/01/2010CN101352519B Chinese herbal medicine composition for treating diabetics
12/01/2010CN101337920B Phenylalanyl pyrrolidine derivates, preparation method and application thereof
12/01/2010CN101318021B Method for preparing composite vitamin beta-cyclodextrin clathrate compound
12/01/2010CN101229218B Vanadium compounds for curing diabetes and preparing method thereof
12/01/2010CN101209975B Levulorotation carnitine calcium fumarate and its preparing method and use
12/01/2010CN101204571B Edible Chinese traditional medicine composite for diabetes mellitus and preparation method thereof
12/01/2010CN101156689B A functional food for diabetic
12/01/2010CN101153039B 13, 13a- dihydro berberine derivant and pharmaceutical composition
12/01/2010CN101108194B Method of eliminating sodium chloride in iron-dextran complex compound water solution and device thereof
12/01/2010CN101095698B Use of Clostridium Butyricum for preventing and treating foetid faeces toxin syndrome and disease
12/01/2010CN101090717B Use of glycine in preparing composition for regulating weight and size of animals
12/01/2010CN101069746B Composition containing sugar-reducing medicine and antiplatelet medicine
12/01/2010CN101062256B Chinese traditional combination medicine for treating diabetes
12/01/2010CN101011100B Ice cream powder
12/01/2010CN101002758B Use of composition for treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
11/2010
11/30/2010US7842807 Process for preparing the calcium salt of rosuvastatin
11/30/2010US7842706 Pharmaceutical composition
11/30/2010US7842699 administering 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or salts, for the treatment of dermatitis, Crohn's disease, inflammatory bowel disease, transplant rejection, lupus, multiple sclerosis, arthritis, psoriasis, diabetes and autoimmune diseases
11/30/2010US7842683 Beta-lactam antibiotics and beta-lactamase inhibitors provide significant neurotropic effects in warm-blooded vertebrates evidenced inter alia by anxiolytic and antiaggressive behavior modification and enhanced cognition
11/30/2010US7842501 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/30/2010CA2583492C Naphthalene and isoquinoline derivatives bearing a pyridyl group for the treatment of skin lesions
11/30/2010CA2460682C Ester compound and medical use thereof
11/30/2010CA2440218C Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
11/30/2010CA2432809C Heteroaryl urea neuropeptide y y5 receptor antagonists
11/30/2010CA2299295C Substituted tetrahydropyrane derivatives and method for producing same
11/30/2010CA2193969C Peptide, a method of obtaining it and a pharmaceutical compound based on it
11/25/2010WO2010135714A2 Methods for modulating adipocyte expression using microrna compositions
11/25/2010WO2010135684A2 Bone morphogenetic proteins for the treatment of insulin resistance
11/25/2010WO2010135506A1 Process for the preparation of 4- [6-(6-methanesulfonyl-2-methyl-pyridin-3-ylamino) -5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
11/25/2010WO2010135429A2 Compositions for modulating a kinase cascade and methods of use thereof
11/25/2010WO2010134756A2 Composition comprising green tea extract
11/25/2010WO2010134614A1 SELF-EMULSIFYING COMPOSITION OF ω3 FATTY ACID
11/25/2010WO2010134595A1 Anti-obesity agent comprising compound containing benzotropolone ring
11/25/2010WO2010134373A1 Prophylactic and/or therapeutic agent for metabolic syndrome
11/25/2010WO2010134032A1 Use of inhibitors of zdhhc2 activity for modulation of adipogenesis
11/25/2010WO2010133970A1 Targeting micrornas for metabolic disorders
11/25/2010WO2010133211A1 Decolorized extracts of the plant pandanus conoideus
11/25/2010WO2010114215A3 Composition for preventing or treating obesity, dyslipidemia, fatty liver or insulin resistance syndrome, comprising camphor as an active ingredient
11/25/2010WO2010108937A3 Drug fusions and conjugates
11/25/2010WO2010088375A3 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
11/25/2010WO2010081079A3 Composition and method for treatment of diabetes
11/25/2010WO2010080730A3 Methods and materials for delivering bile acids
11/25/2010WO2010068728A3 Engineering functional tissue from cultured cells
11/25/2010US20100299769 Novel peptide involved in energy homeostasis
11/25/2010US20100298442 1-Amino-alkyl-cyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
11/25/2010US20100298437 Use of citrulline for treating undernutrition conditions
11/25/2010US20100298402 Stilbene derivatives as pstat3/il-6 inhibitors
11/25/2010US20100298383 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
11/25/2010US20100298379 Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound
11/25/2010US20100298378 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
11/25/2010US20100298367 Conformationally Constrained Carboxylic Acid Derivatives Useful for Treating Metabolic Disorders
11/25/2010US20100298362 Process for the preparation of 4-[6-(6-methanesulfonyl-2-methyl-pyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
11/25/2010US20100298358 Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors
11/25/2010US20100298355 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
11/25/2010US20100298349 Thienopyrimidine compounds and compositions
11/25/2010US20100298348 Method of Decreasing Ubiquitylated Protein Levels
11/25/2010US20100298347 Substituted 2-naphthoic acids as antagonists of gpr105 activity
11/25/2010US20100298334 N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
11/25/2010US20100298333 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
11/25/2010US20100298332 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands
11/25/2010US20100298330 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
11/25/2010US20100298325 Pyridine derivatives for the treatment of amyloid-related diseases
11/25/2010US20100298322 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
11/25/2010US20100298316 Benzothiazoles Having Histamine H3 Receptor Activity
11/25/2010US20100298315 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmnaceutical compositions and novel use as met inhibitors
11/25/2010US20100298314 Novel jnk inhibitors
11/25/2010US20100298312 Substituted pyrimidinyl-amines as protein kinase inhibitors
11/25/2010US20100298310 Thiazole Derivatives as Kinase Inhibitors
11/25/2010US20100298309 Tricyclic triazolic compounds
11/25/2010US20100298308 Compositions and methods for bone formation and remodeling
11/25/2010US20100298307 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
11/25/2010US20100298306 (1,4-Diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone Ligands for Nicotinic Acetylcholine Receptors, Useful for the Treatment of Disease
11/25/2010US20100298298 Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
11/25/2010US20100298292 Modulators of 5-ht receptors and methods of use thereof
11/25/2010US20100298291 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2010US20100298288 Cetp inhibitors derived from benzoxazole arylamides
11/25/2010US20100298285 Biclycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof
11/25/2010US20100298278 Inhibitors of beta-secretase for the treatment of alzheimer's disease
11/25/2010US20100298276 Thyroid receptor ligands
11/25/2010US20100298273 Lipid mixture for infant nutrition
11/25/2010US20100298269 Prodrugs of cgrp receptor antagonists
11/25/2010US20100298263 Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
11/25/2010US20100298261 Edible compositions for lowering cholesterol
11/25/2010US20100298243 Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
11/25/2010US20100298239 Peptide with multiple epitopes
11/25/2010US20100298236 Soluble gp130 muteins with improved binding activity
11/25/2010US20100298221 2-phenoxy nicotine acid derivative and use thereof
11/25/2010US20100298217 Csf-1r mutants
11/25/2010US20100298216 Casein Derived Peptides And Uses Thereof in Therapy
11/25/2010US20100298215 Synthetic apolipoprotein e mimicking polypeptides and methods of use
11/25/2010US20100298214 Treatment of autoimmune disease